METTL3 and type 2 diabetes mellitus: In the β-cells of both T2D patients and a diabetic mouse model, decreased expression of METTL3/14 impairs the maturation of β-cells by decreasing the stability of MarfA mRNA, which leads to hyperglycemia and hypoinsulinemia.88